LINC01232 and nonpapillary renal cell carcinoma: Through the starBase platform, the binding site of LINC01232 to miR-204-5p was predicted (Figure 4(A)), and the expression levels of LINC01232 and miR-204-5p were also found to be significantly negatively correlated in ccRCC (Figure 4(B), r= −0.220, p < .001).